The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

Recruiting now

Conditions studied: Cancer of Stomach, Oesophageal Cancer, Gastric Cancer, Gastric Adenocarcinoma, GI Cancer, GIST, Neuroendocrine Tumors, Gastric Neoplasm, Esophageal Neoplasms

In brief

To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions

Key facts

Study ID

NCT05804331

Run by

Western Sydney Local Health District

People needed

500

Starts

2023-03-14

Expected to finish

2028-09-14

Last updated by the study team

2025-03-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• UGI neoplastic lesions > 10mm
• Lesions for ESD limited to the mucosal and/or submucosal layer OR
• Lesions for EFTR limited to the muscularis propria layer OR
• Lesions for STER limited to the submucosal and/or muscularis propria layer
• Aged 18 years or older

You may not qualify if…

• Age less than 18
• Unable to give informed consent
• Pregnant or lactating patients
• Patients with bleeding diathesis or who cannot discontinue ADP blockers (e.g. clopidogrel, prasugrel) or antithrombotics (e.g. warfarin, dabigatran) periprocedurally

Where it is running

• Westmead Hospital — Sydney, New South Wales, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.